- Country: Czech Republic
- Summary: "cytostatic, Protein Kinase Inhibitor with Sorafenib Tosillate Content"
- CZT Ref No: 64404941
- Deadline: 29 Mar 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: VZ0135422
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Order name: "Cytostatic, protein kinase inhibitor with sorafenib tosillate"
Brief description: The subject of performance of the public contract is continuous and repeated delivery of the medicinal product-cytostatics, protein kinase inhibitor SorafeniB tosilate 200 mg in one tablet Original order number: Z2016-003695
System number: P22V00213966
Internal number: DNS-01/16-VZ-06/22
Tender deadline: 29. 03. 2022 13:30:00
Contact Person
Jana Zakilová
+420 597 373 452
, Jana.chytilova@fno.cz - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN"cytostatic, Protein Kinase Inhibitor with Sorafenib Tosillate Content" - Czech Tender
The UNIVERSITY HOSPITAL OSTRAVA, a Government sector organization in Czech Republic, has announced a new tender for "cytostatic, Protein Kinase Inhibitor with Sorafenib Tosillate Content". This tender is published on CzechTenders under CZT Ref No: 64404941 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-03-29.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
